P J K Pearson1, S A Lewis, J Britton, A Fogarty. 1. Division of Respiratory Medicine, University of Nottingham, Clinical Science Building, Nottingham City Hospital, Nottingham NG5 1PB, UK.
Abstract
BACKGROUND: Increased dietary vitamin E intake is associated with a reduced incidence of asthma, and combinations of antioxidant supplements including vitamin E are effective in reducing ozone induced bronchoconstriction. A study was undertaken to investigate the effect of supplementation with vitamin E for 6 weeks on bronchial hyperresponsiveness in atopic adults with asthma. METHODS: 72 participants from a clinical trial register of adults with asthma were randomised to receive 500 mg natural vitamin E or matched placebo for 6 weeks in a placebo controlled, double blind parallel group clinical trial. Inclusion criteria included age 18-60 years, maintenance treatment of at least one dose of inhaled corticosteroid per day, a positive skin prick test to one of three common allergens, and bronchial hyperresponsiveness to methacholine (defined as a dose provoking a 20% fall in forced expiratory volume in 1 second (FEV(1)) (PD(20)) of 12.25 micromol). Secondary outcomes were FEV(1), forced vital capacity, mean morning and evening peak flow, symptom scores, bronchodilator use, and serum immunoglobulin E levels. RESULTS: In the primary intention to treat analysis the change in PD(20) was similar in the vitamin E and placebo groups with a mean difference of +0.25 doubling doses of methacholine (95% confidence interval -0.67 to +1.16 greater with vitamin E). There was no effect of vitamin E supplementation on any other measure of asthma control, either in the intention to treat or per protocol analysis. There was also no effect of vitamin E supplementation on serum immunoglobulin levels. CONCLUSION:Dietary supplementation with vitamin E adds no benefit to current standard treatment in adults with mild to moderate asthma.
RCT Entities:
BACKGROUND: Increased dietary vitamin E intake is associated with a reduced incidence of asthma, and combinations of antioxidant supplements including vitamin E are effective in reducing ozone induced bronchoconstriction. A study was undertaken to investigate the effect of supplementation with vitamin E for 6 weeks on bronchial hyperresponsiveness in atopic adults with asthma. METHODS: 72 participants from a clinical trial register of adults with asthma were randomised to receive 500 mg natural vitamin E or matched placebo for 6 weeks in a placebo controlled, double blind parallel group clinical trial. Inclusion criteria included age 18-60 years, maintenance treatment of at least one dose of inhaled corticosteroid per day, a positive skin prick test to one of three common allergens, and bronchial hyperresponsiveness to methacholine (defined as a dose provoking a 20% fall in forced expiratory volume in 1 second (FEV(1)) (PD(20)) of 12.25 micromol). Secondary outcomes were FEV(1), forced vital capacity, mean morning and evening peak flow, symptom scores, bronchodilator use, and serum immunoglobulin E levels. RESULTS: In the primary intention to treat analysis the change in PD(20) was similar in the vitamin E and placebo groups with a mean difference of +0.25 doubling doses of methacholine (95% confidence interval -0.67 to +1.16 greater with vitamin E). There was no effect of vitamin E supplementation on any other measure of asthma control, either in the intention to treat or per protocol analysis. There was also no effect of vitamin E supplementation on serum immunoglobulin levels. CONCLUSION: Dietary supplementation with vitamin E adds no benefit to current standard treatment in adults with mild to moderate asthma.
Authors: Rob McConnell; Kiros Berhane; Frank Gilliland; Stephanie J London; Talat Islam; W James Gauderman; Edward Avol; Helene G Margolis; John M Peters Journal: Lancet Date: 2002-02-02 Impact factor: 79.321
Authors: Isabelle Romieu; Juan José Sienra-Monge; Matiana Ramírez-Aguilar; Martha María Téllez-Rojo; Hortensia Moreno-Macías; Norma Isabel Reyes-Ruiz; Blanca Estela del Río-Navarro; María Xóchitl Ruiz-Navarro; Gary Hatch; Ralph Slade; Mauricio Hernández-Avila Journal: Am J Respir Crit Care Med Date: 2002-09-01 Impact factor: 21.405
Authors: Vittorio Pengo; Anthonie W A Lensing; Martin H Prins; Antonio Marchiori; Bruce L Davidson; Francesca Tiozzo; Paolo Albanese; Alessandra Biasiolo; Cinzia Pegoraro; Sabino Iliceto; Paolo Prandoni Journal: N Engl J Med Date: 2004-05-27 Impact factor: 91.245
Authors: Jessica Wiser; Neil E Alexis; Qing Jiang; Weidong Wu; Carole Robinette; Robert Roubey; David B Peden Journal: Free Radic Biol Med Date: 2008-03-12 Impact factor: 7.376
Authors: Yueh-Ying Han; Josh Blatter; John M Brehm; Erick Forno; Augusto A Litonjua; Juan C Celedón Journal: Lancet Respir Med Date: 2013-07-31 Impact factor: 30.700